Chiusura precedente | 31,18 |
Aperto | 31,31 |
Denaro | 31,01 x 2200 |
Lettera | 31,38 x 1400 |
Min-Max giorno | 31,12 - 31,44 |
Intervallo di 52 settimane | 28,98 - 37,10 |
Volume | |
Media Volume | 3.681.233 |
Capitalizzazione | 26,63B |
Beta (5 anni mensile) | 1,06 |
Rapporto PE (ttm) | 42,19 |
EPS (ttm) | 0,74 |
Prossima data utili | 23 ott 2023 - 27 ott 2023 |
Rendimento e dividendo (futuro) | 1,12 (3,59%) |
Data ex dividendo | 30 ago 2023 |
Stima target 1A | 38,10 |
Sales increased sequentially and decreased year over year, in line with management expectations for the current weak end-market environment; Sequential margin expansion and $310 million of free cash flow reflect progress on pricing and productivity actions, with continued improvement expected in the second half; In the third quarter, management expects core sales of approximately $3.5 billion and core EPS to be about the same or slightly better than in the second quarterCorning, N.Y., July 25, 2
The vial technology will help drug manufacturers meet their sustainability goals while enabling faster, safer filling-line operationsCORNING, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Corning Incorporated (NYSE: GLW) today launched Corning® Viridian™ Vials, the latest innovation in its expanding pharmaceutical glass-packaging portfolio. Viridian Vials bring performance and sustainability together. The new technology can improve filling-line efficiency by up to 50% while reducing vial-manufacturing
CORNING, N.Y., June 21, 2023 (GLOBE NEWSWIRE) -- Corning Incorporated’s (NYSE: GLW) Board of Directors today declared a quarterly dividend of $0.28 per share. The dividend will be payable on Sept. 28, 2023, to shareholders of record on Aug. 31, 2023. Caution Concerning Forward-Looking StatementsThe statements contained in this release and related comments by management that are not historical facts or information and contain words such as “will,” “believe,” “anticipate,” “expect,” “intend,” “pla